TrialInvestigational new drugs2021

Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer.

Benjamin A Gartrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.